Morgan Stanley analyst Ronald Kamdem maintains Boston Properties (NYSE:BXP) with a Equal-Weight and lowers the price target from $104 to $80.
Berenberg Maintains Buy on Eli Lilly, Raises Price Target to $375
Berenberg analyst Kerry Holford maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $345 to $375.